Elutia ELUT
NASDAQ ELUT
$0.79 -0.01 (-1.25%)
As of: Sep 10, 2026 · 3:59 PM EDT

Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)

Elutia's (ELUT) quarterly Total Non-Current Liabilities came in at $24.7 million in Q2 2026, down 62.92% year-over-year from $66.7 million in Q2 2025, and down 15.54% quarter-over-quarter from $29.3 million in Q1 2026.

Analysis

Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Elutia has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $24.7 million for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities fell 62.92% year-over-year to $24.7 million; the TTM figure through Jun 2026 stood at $24.7 million (down 62.92% YoY), while the FY2025 annual figure was $31.6 million, down 52.42% from the prior year.
  • Total Non-Current Liabilities came in at $24.7 million for Q2 2026 at Elutia, down from $29.3 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $76.5 million in Q3 2023 to a low of $24.7 million in Q2 2026.
  • Average Total Non-Current Liabilities over 5 years is $58.0 million, with a median of $66.5 million recorded in 2024.
  • Year-over-year, Total Non-Current Liabilities surged 83.13% in 2022 and sank 62.92% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $68.0 million in 2022, then advanced by 1.93% to $69.3 million in 2023, then dropped by 4.27% to $66.3 million in 2024, then tumbled by 52.42% to $31.6 million in 2025, then declined by 21.59% to $24.7 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $24.7 million in Q2 2026, $29.3 million in Q1 2026, and $31.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 40.46 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 2.57 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 3.68 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.44 Bn
10 Elutia 35.28 Mn 15.39 Mn 1.45 Mn 24.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.74 Mn
Mar 31, 2026 29.29 Mn
Dec 31, 2025 31.55 Mn
Sep 30, 2025 69.30 Mn
Jun 30, 2025 66.73 Mn
Mar 31, 2025 63.67 Mn
Dec 31, 2024 66.31 Mn
Sep 30, 2024 70.12 Mn
Jun 30, 2024 67.22 Mn
Mar 31, 2024 66.16 Mn
Dec 31, 2023 69.27 Mn
Sep 30, 2023 76.45 Mn
Jun 30, 2023 68.86 Mn
Mar 31, 2023 67.06 Mn
Dec 31, 2022 67.96 Mn
Sep 30, 2022 60.25 Mn
Jun 30, 2022 42.75 Mn
Mar 31, 2022 36.85 Mn
Dec 31, 2021 37.11 Mn
Sep 30, 2021 35.49 Mn